At Research in Real Life, we conduct observational database research to investigate real world evidence for the comparative effectiveness and safety of different medical interventions for the treatment of disease. We specialize in establishing true disease burden and factors associated with poorly controlled disease and adverse outcomes.

A deeper understanding of the burden of disease and risk-factors for poorly controlled disease as well as understanding the effectiveness of drugs and patient management strategies in real life can drive better disease management and lead to better patient outcomes.

Research in Real Life’s studies are registered on research registers and published in key, peer-reviewed health journals. We work closely with academic, professional and industry partners to establish clear standards for high quality real life research, especially in the areas of observational database studies. Having strongly established its expertise in the study of asthma and COPD, Research in Real Life’s work now extends into other disease areas, including cardiovascular diseases, diabetes and allergies.


Blood eosinophil count and asthma disease burden

Marjan Kerkhof and Elizabeth Hillyer, members of the RiRL team, have recently published the manuscript “Blood eosinophil count and prospective annual asthma disease burden” in The Lancet Respiratory Medicine, Vol. 3, No. 11, p849–858. They […]

Issue panel at ISPOR Congress, Milan

David Price, Brett McQueen and colleagues presented their issue panel at ISPOR discussing the most appropriate evidence for making coverage and reimbursement decisions (i.e., health technology assessment). The issue panel centered around a debate on […]